Searchable abstracts of presentations at key conferences in endocrinology

ea0038p84 | Clinical practice/governance and case reports | SFEBES2015

Decreased conscious level and a renal mass

Dales Jolyon , Prouten Jenny , Macriyiannis Thrasos , Kong Marie-France

A 70-year-old lady with known hypothyroidism and ischaemic heart disease (previous CABG) presented with tonic clonic seizures. Her BP was 245/110. She was admitted to the intensive care unit. MRI brain showed subcortical oedema with subarachnoid bleed in the left temporal parietal region. Investigation for malignant hypertension showed a solid mass measuring 17×17×11 cm completely replacing the left kidney on CT-scanning. She was discharged home on sodium valproate w...

ea0038p319 | Pituitary | SFEBES2015

The accuracy of bilateral inferior petrosal sinus cannulation and usefulness of prolactin adjustment in one Scottish centre

Devine Kerri , Smith Karen , Robertson Iain , Perry Colin , Freel Marie

Bilateral inferior petrosal sinus sampling (BIPSS) is the gold standard investigation in Cushing’s disease for identifying the pituitary as the ACTH source. This technique aims to demonstrate a gradient of central:peripheral ACTH levels of >2:1 in such patients, or >3:1 after CRH stimulation. In patients without significant pituitary MRI abnormalities this facilitates neurosurgical exploration.The test is limited by difficulties in achieving...

ea0035p929 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Malignancies in patients with pituitary adenomas

Filipponi Silvia , Cantore Giampaolo , Jaffrain-Rea Marie-Lise

Abstract: Generously supported by IPSEN)-->Pituitary adenomas (PA) may occur in association with malignancies. Although an increased risk of cancer has been reported in acromegalics, this has been poorly studied in patients with other phenotypes. We wished to evaluate the prevalence of recognized malignancies in PA.Material and Methods: A series of 422 consecutive PA patients followed at the Neuromed Institute ...

ea0061p001 | (1) | OU2019

GLP-1 agonist use in the management of obesity in Type 2 Diabetes: an Irish tertiary hospital experience

Tansey David J , Healy Marie Louise , Pazderska Agnieszka

Background: In Clinical Trials, Glucagon-like peptide-1 (GLP-1) receptor analogs liraglutide and semaglutide have been shown to cause weight loss, reduced systolic blood pressure, effectiveglycemic control with low rates of hypoglycemia, in patients with type 2 diabetes. Through a retrospective clinical study, the authors aimed to assess the clinical effectiveness of GLP-1 receptor agonists in the management of obesity in patients with Type 2 Diabetes.Me...

ea0058oc7.1 | Oral Communications 7 | BSPED2018

DeAPP (Diabetes Education APP): using flipped learning to deliver structured education in newly diagnosed type 1 diabetes patients

Greening James , Lee Sarah Lickwood , Atkins Marie , Terris David

Background: At diagnosis of diabetes is a critical time in the life course of diabetes. This a critical time for patient take on knowledge and using it (ref). Utilisation of this information is suboptimal due to logistical factors such as ward environment, time constraints of staff, psychological impact of the diagnosis. Current models of education are mainly didactic with limited impact in some patients.Aims: In collaboration with demontfort design unit...

ea0034p184 | Neoplasia, cancer and late effects | SFEBES2014

Diagnosis of adrenocortical carcinoma; urinary steroid profiles measured by GC:MS

McManus Frances , Hannay Jonathan , O'Dwyer Patrick , Shapiro David , Freel Marie

Introduction: Gas chromatography/mass spectrometry based steroid profiling has been proposed as a tool for differentiating adrenocortical carcinoma (ACC) from benign adrenocortical adenoma (ACA). We retrospectively examined urinary steroid profiles from ten patients with ACC and 14 patients with ACA to determine, if the steroid profiles were predictive in distinguishing benign from malignant disease.Methods: Patients who had undergone adrenalectomy for r...

ea0034p187 | Neoplasia, cancer and late effects | SFEBES2014

MIBG-avidity in genetically distinct phaeochromocytoma and paraganglioma populations

Jack Ross , Lindsay Robert , Bradshaw Nicola , Freel Marie , Perry Colin

Phaeochromocytomas (PHAEOs) and extra-adrenal paragangliomas (PGLs) are rare neuroendocrine tumours. As many as 35% may have an identifiable germline mutation, most commonly in the genes encoding RET, VHL or subunits of succinate dehydrogenase (SDHx).[123I]-labelled metaiodobenzylguanidine (123I-MIBG) scintigraphy is used to localise PHAEOs/PGLs, while 131I-MIBG is used as therapy in malignant disease. Uptake of radioisot...

ea0034p258 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

High serum amylase a contraindication to GLP1 analogue treatment?

Stepien Karolina , Kelly Anne-Marie , Horsman Graham , Younis Naveed

Case: A 41 year-old-Indian woman with type 2 diabetes treated with liraglutide was admitted to the Emergency Department with abdominal pain, nausea, vomiting and bloated abdomen. She was found to have raised amylase at 706 U/l. Abdominal ultrasound and CT scan did not reveal any abnormalities in the pancreas or billary tract and the patient was discharged.She had diabetes for 9 years duration treated with metformin, pioglitazone and liraglutide. Over 2 y...

ea0034p352 | Steroids | SFEBES2014

Urinary steroid profiling by Gas-Chromatography Mass-Spectrometry (GC–MS) is not helpful in the diagnosis of Cushing's Syndrome

Johns Emma , Shapiro David , McManus Frances , Freel Marie

Introduction: The diagnosis of Cushing’s syndrome (CS) can be challenging and there is no single gold standard diagnostic test. Endocrinologists rely on a combination of plasma cortisol (before and after dexamethasone), midnight salivary cortisol and urinary free cortisol (UFC) to make the diagnosis. Assessment of urinary corticosteroids and their metabolites, measured by gas chromatography–mass spectrometry (GC–MS), provide a comprehensive picture of corticoste...

ea0034p405 | Thyroid | SFEBES2014

Scalp metastasis in follicular thyroid cancer: an atypical consequence

Hannon Anne Marie , O'Brien Frank , Fitzgerald Deirdre , Tuthill Antoinette

Follicular thyroid cancer is the second most common cause of thyroid carcinoma. Metastasis occurs in 10–15% of cases. Typical sites of metastasis include bone and lungs, scalp metastasis are rare, with <50 cases reported. We describe two such cases.A retrospective chart review was performed on these patients, examining presentation, treatment and subsequent outcomes.Patient 1. An abnormal lesion was noted on a routine ches...